In vitro anti-leukemic effect of Wharton’s jelly derived mesenchymal stem cells
Molecular Biology Reports · 2024
DOI: 10.1007/s11033-024-09512-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Biology Reports, 2024. Verfasst von Mediha Süleymanoğlu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Istanbul Faculty of Medicine, Department of Medical Biology, Istanbul University, Fatih, Istanbul, 34093, Turkey. mediha.suleymanoglu@istanbul.edu.tr. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Wharton Jelly, Coculture Techniques, Apoptosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: Bilimsel Araştirma Projeleri Birimi, Istanbul Üniversitesi.
Abstract (Originalsprache)
BACKGROUND: Mesenchymal stem cells (MSCs) have the ability to self-renew and are multi-potent. They are a primary candidate for cell-based therapy due to their potential anti-cancer effects. The aim of this study was to evaluate the in vitro anti-leukemic effect of Wharton's Jelly-derived MSC (WJ-MSC) on the leukemic cell lines K562 and HL-60. METHODS: In this present study, WJ-MSCs were isolated from human umbilical cord. The cells were incubated according to the standard culture conditions and characterized by flow cytometry. For experiments, WJ-MSC and leukemic cells were incubated in the direct co-culture at a ratio of 1:5 (leukemia cells: WJ-MSC). HUVEC cells were used as a non-cancerous cell line model. The apoptotic effect of WJ-MSCs on the cell lines was analyzed using Annexin V/PI apoptosis assay. RESULTS: After the direct co-culture of WJ-MSCs on leukemic cell lines, we observed anti-leukemic effects by inducing apoptosis. We had two groups of determination apoptosis with and without WJ-MSCs for all cell lines. Increased apoptosis rates were observed in K562 and HL-60 cell lines, whereas the apoptosis rates in HUVEC cells were low. CONCLUSIONS: MSCs are known to inhibit the growth of tumors of both hematopoietic and non-hematopoietic origin in vitro. In our study, WJ-MSC treatment strongly inhibited the viability of HL-60 and K562 and induced apoptosis. Our results also provided new insights into the inhibition of tumor growth by WJ-MSCs in vitro. In the future, WJ-MSCs could be used to inhibit cancer cells in clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Istanbul Faculty of Medicine, Department of Medical Biology, Istanbul University, Fatih, Istanbul, 34093, Turkey. mediha.suleymanoglu@istanbul.edu.tr.
- Istanbul Faculty of Medicine, Department of Medical Biology, Istanbul University, Fatih, Istanbul, 34093, Turkey.
- Bakırköy Sadi Konuk Education and Research Hospital, University of Health Sciences, Istanbul, Turkey.
- Istanbul Faculty of Medicine, Department of Physiology, Istanbul University, Fatih, Istanbul, 34093, Turkey.
- Istanbul Faculty of Medicine, Department of Microbiology, Istanbul University, Fatih, Istanbul, 34093, Turkey.
- Istanbul Faculty of Medicine, Department of Pediatric Hematology, Istanbul University, Fatih, Istanbul, 34093, Turkey.
Förderung
- Bilimsel Araştirma Projeleri Birimi, Istanbul Üniversitesi
Zitieren
APA
Süleymanoğlu, M., Erol Bozkurt, A., Abatay Sel, F., Özdemir, İ. A., Savran Oğuz, F., Kuruca, D. S., Aktaş, Z., Karakaş, Z., & Öncül, M. O. (2024). In vitro anti-leukemic effect of Wharton’s jelly derived mesenchymal stem cells. Molecular Biology Reports. https://doi.org/10.1007/s11033-024-09512-7
Vancouver
Süleymanoğlu M, Erol Bozkurt A, Abatay Sel F, Özdemir İA, Savran Oğuz F, Kuruca DS, et al. In vitro anti-leukemic effect of Wharton’s jelly derived mesenchymal stem cells. Molecular Biology Reports. 2024. doi:10.1007/s11033-024-09512-7
BibTeX
@article{Sleymanolu2024,
author = {Süleymanoğlu, Mediha and Erol Bozkurt, Ayşe and Abatay Sel, Figen and Özdemir, İsa Aykut and Savran Oğuz, Fatma and Kuruca, Dürdane Serap and Aktaş, Zerrin and Karakaş, Zeynep and Öncül, Mustafa Oral},
title = {In vitro anti-leukemic effect of Wharton’s jelly derived mesenchymal stem cells},
journal = {Molecular Biology Reports},
year = {2024},
doi = {10.1007/s11033-024-09512-7}
}
EUVIMED